» Articles » PMID: 29503909

Radiation Optic Neuropathy and Retinopathy with Low Dose (20 Gy) Radiation Treatment

Overview
Specialty Ophthalmology
Date 2018 Mar 6
PMID 29503909
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To report a case of optic neuropathy and retinopathy from a dose of radiation traditionally thought to be safe to the visual system and discuss strategies for preventing vision loss when using radiation to treat intraocular tumors.

Observations: A 44-year-old woman presented with new, painless vision loss in the left eye eighteen months after receiving proton beam radiotherapy (20 Gy dose delivered in two 10 Gy fractions) for a uveal metastasis of lung cancer. The dilated funduscopic examination revealed optic disc swelling and retinal hemorrhages and an MRI of the brain and orbits demonstrated enhancement of the left optic nerve head, findings consistent with radiation optic neuropathy (RON) and retinopathy. Risk factors for developing RON included coincident use of oral chemotherapy and relatively large fractionated doses of radiation.

Conclusions And Importance: Though cumulative radiation doses to the anterior visual pathway of less than 50 Gy are traditionally felt to be safe, it is important to consider not just the total exposure but also the size of individual fractions. The single-dose threshold for RON in proton beam treatment has yet to be defined. Our case suggests that fractions of less than 10 Gy should be delivered to minimize the risk of optic nerve injury.

Citing Articles

Does occupational radiation exposure affect retinal nerve fiber thickness?.

Koc H, Ozen S Int Ophthalmol. 2023; 43(12):4831-4836.

PMID: 37840074 DOI: 10.1007/s10792-023-02885-x.


Contour Variability in Thyroid Eye Disease with Compressive Optic Neuropathy Treated with Radiation Therapy.

Nanda T, Sanchez A, Purswani J, Wu C, Kazim M, Wang T Adv Radiat Oncol. 2020; 5(5):804-808.

PMID: 33089016 PMC: 7560569. DOI: 10.1016/j.adro.2020.02.005.


Radiation-Induced Cerebro-Ophthalmic Effects in Humans.

Loganovsky K, Marazziti D, Fedirko P, Kuts K, Antypchuk K, Perchuk I Life (Basel). 2020; 10(4).

PMID: 32316206 PMC: 7235763. DOI: 10.3390/life10040041.

References
1.
Kramer S . The hazards of therapeutic iradiation of the central nervous system. Clin Neurosurg. 1968; 15:301-18. DOI: 10.1093/neurosurgery/15.cn_suppl_1.301. View

2.
Ove R, Kelman S, Amin P, Chin L . Preservation of visual fields after peri-sellar gamma-knife radiosurgery. Int J Cancer. 2001; 90(6):343-50. DOI: 10.1002/1097-0215(20001220)90:6<343::aid-ijc6>3.0.co;2-h. View

3.
Gragoudas E, Li W, Lane A, Munzenrider J, Egan K . Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology. 1999; 106(8):1571-7; discussion 1577-8. DOI: 10.1016/S0161-6420(99)90455-4. View

4.
Leber K, Bergloff J, Pendl G . Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg. 1998; 88(1):43-50. DOI: 10.3171/jns.1998.88.1.0043. View

5.
Levin L, Gragoudas E, Lessell S . Endothelial cell loss in irradiated optic nerves. Ophthalmology. 2000; 107(2):370-4. DOI: 10.1016/s0161-6420(99)00054-8. View